Documente Academic
Documente Profesional
Documente Cultură
www.cass.city.ac.uk/marc
Senior Sponsors
Sponsor
Overview
February 2012
February 2012
Exhibit 1: The evolution of average actual, sufficient and excess cash between 2006 and 2010
FTSE All-Share
Sufficient
Actual
40%
Excess
40%
30%
30%
20%
20%
10%
10%
0%
0%
-10%
-10%
-20%
-20%
-30%
50%
-30%
-40%
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
Exhibit 2: Industry breakdown of sufficient and excess cash for 2009 and 2010
60%
Healthcare
50%
Consumer
Services
Industrials
40%
Technology
Telecom
Consumer
Goods
Basic Materials
30%
20%
10%
0%
2009
2010
2009
2010
2009
2010
2009
Sufficient Cash
2010
2009
Excess Cash
2010
2009
Actual Cash
2010
2009
2010
2009
2010
Exhibit 1 shows the evolution of annual average sufficient, excess and actual cash (all deflated by net assets) over the sample period. Excess cash is measured on the right axis, whereas
actual and sufficient cash reserves as well as the percentage yearly change in FTSE All-Share Index are measured on the left axis. The level of sufficient and excess cash must add up to the
actual cash reserves at a given companys disposal according to our methodology. Exhibit 2 shows the breakdown of average actual cash levels into sufficient and excess cash per industry
for 2009 and 2010. Please refer to the Data and Methodology section of this report for further details on the sufficient and excess cash estimation procedure.
3
February 2012
February 2012
February 2012
February 2012
as
replacing
defunct
equipment
and
machinery, as well as to expand business
operations. In order to be directly comparable
to the other spending strategies, we need to
disentangle the capital expenditure which is
used to maintain company operations from
that which is used to grow the business
organically. We distinguish between these two
types of spending by taking the capital
expenditure less depreciation as a proxy for
spending for the purpose of expansion.
In summary, the analysis suggests that
companies which keep excess cash at
hand rather than spending it perform worst
and are accordingly penalised by the
market (-15%). In contrast, companies
which are able to seize profitable
investment opportunities through engaging
in acquisitions or returning funds to
shareholders, when they do not face any
viable opportunities to expand, outperform
the firms which follow other spending
strategies. The reason why companies
which use excess cash for organic growth
neither out- nor underperform their
respective benchmark could be that this
form of business improvement or
expansion is not a strategy that is
aggressive enough to generate returns in
excess of the market over a three-year
period. It is also plausible that companies
lack efficient communication techniques
with regard to their internal growth
strategies. Whereas takeovers and share
repurchases tend to be highly publicised
events and are therefore less likely to
remain unnoticed by investors, increases
in expenditure for organic growth are much
more difficult for investors to identify. The
performance results associated with
spending on organic growth could suggest
that companies are not able to convey their
spending plans adequately to the investor
community.
February 2012
Exhibit 3: Buy-and-hold returns for each spending strategy performed in the first year following a period with positive excess cash
Buy-and-hold returns
15%
11%
10%
7%
5%
3%
1%
0%
0%
7%
0%
-5%
-1%
-1% 0% 0% 0%
-5%
-10%
0%
-1%
-5% -5%
-9%
-3%
-4%
-1%
-4%
-5%
-10%
M&A
Month 12
Capex
Dividends
-9%
-11%
-15%
Month 1
All with excess cash
-1%
-2%
Buyback
Month 24
Reduction in long-term debt
Month 36
No spending
All with
excess cash
M&A
Capex
Dividends
Buyback
Reduction in
long-term debt
No spending
Month 1
Month12
Month 24
-4%
-10%
-5%
1%
-4%
2%
-3%
-11%
-7%
-2%
-11%
0%
-4%
2%
16%
-2%
-10%
-7%
-55%
-27%
-19%
Month 36
-1%
14%
-2%
4%
15%
-1%
-15%
Exhibit 3 presents the performance in terms of the average returns of the five different portfolios consisting of all of the companies which opted for a given spending strategy in
order to utilise the excess cash at their disposal as well as that of those companies which decided to keep the excess funds to hand. In addition, Exhibit 4 presents the riskadjusted performance (i.e. the average return divided by the standard deviation of returns) of the aforementioned portfolios The M&A portfolio includes all of the sample
companies which used their excess cash for the purpose of M&A and in which the method of payment was all cash; the Capex portfolio includes all of the sample companies
which used their excess cash for the purpose of organic growth through capital expenditure; the Dividends portfolio includes all of the sample companies which used their
excess cash for the purpose of distributing it in the form of cash dividends; the Buyback portfolio includes all of the sample companies which used their excess cash for the
purpose of repurchasing a portion of their shares; and the Reduction in long-term debt portfolio includes all of the sample companies which used their excess cash for the
purpose of reducing their indebtedness. It should be noted that, in order to be included in this graph, each spending strategy must have been adopted in the first year following
a period of positive excess cash. The returns have been calculated on the basis of the Buy-and-Hold Abnormal Returns (BHAR) methodology. Please refer to the Data and
Methodology section of this report for a detailed description of the method used for distinguishing between the different spending options as well as that used in order to
evaluate the share price performance of each portfolio.
8
February 2012
10
11
12
13
15
February 2012
16
18
19
February 2012
Company-specific factors
Factors
Current cash flow
Managements
expectation of the
degree to which future
cash flow will meet the
need for planned
investments
Size
Growth opportunities
Basic
Materials
Cost of debt
Economic productivity
Economic growth
Market liquidity
Industrials
Consumer
Goods
Consumer
Services
Oil &
Gas
Technology
Telecommunications
Indebtedness
Liquidity
Macroeconomic
factors
Healthcare
Exhibit 5 shows the different factors which affect the size of sufficient cash reserves for each of the sample industries. These factors are determined on the basis of eight industry-specific
models of sufficient cash. Current cash flow is measured as each companys net cash flow deflated by net assets; Managements expectation of the degree to which future cash flow will
meet the need for planned investments is measured as the consensus analyst forecast of future net cash flow one and two years ahead of the current period; Size is measured as the
natural logarithm of total assets; Growth opportunities are measured as each companys current market-to-book ratio; company Indebtedness is measured as each companys long-term
debt deflated by net assets as of one year before the current period; the Cost of debt for each company was obtained from Bloomberg; Liquidity is measured as the net working capital
deflated by net assets; Economic productivity is measured as the UK productivity index, provided by the Bloomberg database; Economic growth is measured as the annual change in the
MSCI World Index; and Market liquidity is the Bank of Englands liquidity index. For further details on how each variable is constructed please refer to the Data and Methodology section
of this report.
11
February 2012
Notes on Authors
Scott Moeller, Director of MARC and Professor in the Practice of Finance. His research and
teaching focuses on the full range of mergers and acquisitions activities.
Contact: cassmarc@city.ac.uk
February 2012